New research will explore the potential for human challenge studies to accelerate development of a COVID-19 vaccine
Experts from the NHS, academics and the private sector are joining forces with the government to explore and establish human … read more »
EMA begins second rolling review of a COVID-19 vaccine
The European Medicines Agency (EMA) has begun a ‘rolling review’ of data on a vaccine for COVID-19, which is being … read more »
Clinical studies guidance issued by ANVISA
ANVISA – Agência Nacional de Vigilância Sanitária (Brazilian Health Regulatory Agency) has announced new guidance for the conduct of clinical … read more »
NIHR CRN posts impressive figures for research in 2019/20
The Clinical Research Network (CRN) has reported that 732,176 people took part in studies it supported, taking its five-year total … read more »
Cautious optimism for COVID-19 treatment
A British study into the drug dexamethasone appears to show the drug can reduce the risk of death from the … read more »
NIHR issues guidance to restart paused research activities
In response to the declining number of new cases of COVID-19 in England, the National Institute for Health Research (NIHR) … read more »
IVIg-G product approved for phase 3 COVID-19 trial
Octagam, an intravenous immunoglobulin-G (IVIg-G) product has received approval for a phase 3 trial to reduce the effects of COVID-19. … read more »
Global clinical trial of potential COVID-19 drug hydroxychloroquine begins
A multi-national clinical study has begun in the UK to test the potential of the anti-malaria drug hydroxychloroquine to lessen … read more »
First US COVID-19 vaccine trial generates positive results
The first US COVID-19 vaccine trial has been shown to be safe, well-tolerated and to stimulate the immune system of … read more »
EMA meeting of global regulators highlights importance of large-scale COVID-19 clinical trials
The third bi-weekly meeting held by the European Medicines Agency (EMA) under the umbrella of the International Coalition of Medicines … read more »
